Creating safe medicinal molecules with sustainable electrochemistry

Song Lin and collaborators use electrochemistry to selectively synthesize chiral compounds – important in pharmaceuticals – using the reaction’s electrolytes, a completely new strategy. 

Around Cornell

New pesticides provide challenging alternatives to neonicotinoids

Options other than neonicotinoids can help farmers who grow large-seeded vegetable crops such as snap bean, dry bean and sweet corn.

Neurobiology professor named Pew Research Fellow

Antonio Fernandez-Ruiz, assistant professor and Nancy and Peter Meinig Family Investigator in the Life Sciences in the Department of Neurobiology and Behavior in the College of Arts and Sciences, has been awarded a biomedical sciences grant from the Pew Charitable Trusts.

Researchers identify key biomarkers for chronic fatigue syndrome

Researchers developed machine-learning models that can sift through cell-free RNA and identify key biomarkers for chronic fatigue syndrome, a debilitating disease that is difficult to confirm in patients because its symptoms can be easily confused with those of other illnesses.

Dr. Daniel Alonso, inaugural Weill Cornell Medicine-Qatar dean, dies

Dr. Daniel R. Alonso, dean emeritus of Weill Cornell Medicine-Qatar and professor emeritus of pathology and laboratory medicine at Weill Cornell Medicine, died July 31 in Norfolk, Va., at age 88.

Around Cornell

Immunological study provides new insights into post-pandemic return of respiratory viruses

COVID-19 prevention methods such as masking and social distancing also suppressed the circulation of common respiratory diseases, leaving young children lacking immunity to pathogens they otherwise would have been exposed to, a new study reveals. 

Implant treats Type 1 diabetes by oxygenating insulin-producing cells

Cornell researchers have developed an implant system that can treat Type 1 diabetes by supplying extra oxygen to densely packed insulin-secreting cells, without the need for immunosuppression. 

Brain imaging may identify patients likely to benefit from anxiety care app

By understanding differences in how people’s brains are wired, clinicians may be able to predict who’d benefit from a self-guided anxiety care app, according to a clinical trial co-led by Weill Cornell Medicine investigators.

Improving guidelines can help combat deadly bacteria in powdered baby formula

The findings of a new study reveal how the current instructions for reconstituting powdered formula are ambiguous and can fail to protect against potentially fatal food-borne bacteria.